Cargando…
A signaling visualization toolkit to support rational design of combination therapies and biomarker discovery: SiViT
Targeted cancer therapy aims to disrupt aberrant cellular signalling pathways. Biomarkers are surrogates of pathway state, but there is limited success in translating candidate biomarkers to clinical practice due to the intrinsic complexity of pathway networks. Systems biology approaches afford bett...
Autores principales: | Bown, James L., Shovman, Mark, Robertson, Paul, Boiko, Andrei, Goltsov, Alexey, Mullen, Peter, Harrison, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444693/ https://www.ncbi.nlm.nih.gov/pubmed/27302920 http://dx.doi.org/10.18632/oncotarget.8747 |
Ejemplares similares
-
Customizing the Therapeutic Response of Signaling Networks to Promote Antitumor Responses by Drug Combinations
por: Goltsov, Alexey, et al.
Publicado: (2014) -
The visualization toolkit
por: Schroeder, Will
Publicado: (1998) -
A novel mechanism of action of HER2 targeted immunotherapy is explained by inhibition of NRF2 function in ovarian cancer cells
por: Khalil, Hilal S., et al.
Publicado: (2016) -
Systems Analysis of Drug-Induced Receptor Tyrosine Kinase Reprogramming Following Targeted Mono- and Combination Anti-Cancer Therapy
por: Goltsov, Alexey, et al.
Publicado: (2014) -
Visual special effects toolkit in C++ /
por: Wittenburg, Tim, 1955-
Publicado: (1997)